Skip to main content
. 2020 Apr 3;16(1):41–48. doi: 10.5114/aic.2020.93911

Table III.

Management of NSTEMI patients (after propensity score matching)

Parameter Women Men
2005–2007 2012–2014 P-value 2005–2007 2012–2014 P-value
17346 (100%) 17346 (100%) 26059 (100%) 26059 (100%)
Treatment strategy:
 Hospitalisation on cardiology depart. 12000 (69.2) 15420 (88.9) < 0.001 19222 (73.8) 23982 (92.0) < 0.001
 Conservative treatment 11787 (68.0) 2255 (13.0) < 0.001 15032 (57.7) 2315 (8.9) < 0.001
 Coronary angiography 5542 (32.0) 15090 (87.0) < 0.001 10998 (42.3) 23744 (91.1) < 0.001
 Percutaneous coronary intervention 3838 (22.1) 10021 (57.8) < 0.001 8015 (30.8) 16861 (64.7) < 0.001
 Second PCI (non-IRA) during indx hosp. 612 (3.6) 2268 (13.1) < 0.001 1149 (4.4) 2849 (10.9) < 0.001
 PCI with stent implantation 3357 (87.5) 9083 (90.5) < 0.001 7719 (88.9) 15434 (91.3) < 0.001
 PCI with BMS implantation 3192 (83.2) 4115 (41.0) < 0.001 6808 (85.0) 6618 (39.1) < 0.001
 PCI with DES implantation 165 (4.3) 4968 (49.5) < 0.001 311 (3.9) 8816 (52.2) < 0.001
 Intra aortic ballon pump 52 (0.3) 88 (0.5) 0.023 105 (0.4) 143 (0.5) 0.016
Medical treatment during hospitalisation:
 Acetlosalycic acid 15974 (92.1) 14271 (82.3) < 0.001 24244 (93.0) 21671 (83.2) < 0.001
 P2Y12B inhibitor 9041 (52.1) 16096 (92.8) < 0.001 15581 (59.8) 24281 (93.2) < 0.001
 Clopidogrel 7019 (40.5) 16040 (92.5) < 0.001 12625 (48.4) 24243 (93.0) < 0.001
 GPIIb/IIIa inhibitor 371 (2.1) 1318 (7.6) < 0.001 880 (3.4) 2619 (10.1) < 0.001
 Heparin 12949 (74.7) 8919 (51.5) < 0.001 18988 (72.9) 13152 (50.5) < 0.001
 Beta-adrenolytic 13705 (79.0) 11607 (66.9) < 0.001 20499 (78.7) 17790 (68.3) < 0.001
 Calcium channel blocker 1664 (9.8) 2228 (12.8) < 0.001 2032 (7.8) 2878 (11.0) < 0.001
 Statin 13633 (78.6) 12311 (71.0) < 0.001 21050 (80.8) 19224 (73.8) < 0.001
 ACEI/ARB 13616 (78.8) 10529 (60.7) < 0.001 20166 (77.4) 16286 (62.6) < 0.001
 Nitrate 9366 (54.0) 2496 (14.4) < 0.001 13015 (49.9) 3448 (13.2) < 0.001
 Diuretics 6903 (39.8) 5100 (29.4) < 0.001 8082 (31.0) 6326 (24.3) < 0.001

ACEI/ARB – angiotensin-converting enzyme inhibitor/angiotensin receptor blocker, BMS – bare metal stent, DES – drug eluting stent, IRA – infarct-related artery.